Cross-vaccination Study of GSK Biologicals' Lyophilized Formulation of the Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006700/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to cross-vaccinate and collect safety data in terms of
unsolicited Adverse Events (AEs), Serious Adverse Events (SAEs) and potential Immune Mediated
Disease (pIMD) from subjects >= 50 Years of age (YOA) who previously received placebo in
ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229).
提供机构：
Vivli
创建时间：
2021-02-17
